Smart or AI In-Vitro Diagnostics Market
完整報告名稱與涵蓋範圍
Smart or AI In-Vitro Diagnostics Market Size, Share & Trends Analysis Report By Application Area (Cancer Diagnostics, Infectious Disease Testing, Metabolic Testing, Cardiac Testing, Diabetes Testing, and Other Disease Testing), By Technology (Next-Generation Sequencing (NGS)Technology, PCR Technology, Chemistry/IA Technology, Pathology Technology, and Other Technology), By End-User, By Region, And Segment Forecasts, 2025-2034
報告摘要
With a 2024 valuation of USD 1.6 Bn, the global Smart or AI In-Vitro Diagnostics Market is expected to develop to USD 6.2 Bn by 2034, demonstrating a CAGR of 14.8% during the 2025–2034 forecast window.
Smart or AI In-Vitro Diagnostics encompasses The healthcare sector continuously adopts innovative technological innovations that boost clinical efficiency, increase patient care, and improve diagnostic accuracy. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Market momentum is underpinned by surging need advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region expected to deliver the strongest growth trajectory through the forecast period, underpinned by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Smart or AI In-Vitro Diagnostics Market Snapshot
Chapter 4. Global Smart or AI In-Vitro Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Application Estimates & Trend Analysis
5.1. by Application & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
5.2.1. Cancer Diagnostics
5.2.2. Infectious Disease Testing
5.2.3. Metabolic Testing
5.2.4. Cardiac Testing
5.2.5. Diabetes Testing
5.2.6. Other Disease Testing
Chapter 6. Market Segmentation 2: by Technology Estimates & Trend Analysis
6.1. by Technology & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Technology:
6.2.1. Next-Generation Sequencing (NGS) Technology
6.2.2. PCR Technology
6.2.3. Chemistry/IA Technology
6.2.4. Pathology Technology
6.2.5. Other Technology
Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis
7.1. by End-user & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user:
7.2.1. Research
7.2.2. Pharmaceutical Research
7.2.3. Clinical
Chapter 8. Smart or AI In-Vitro Diagnostics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.1.2. North America Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
8.1.3. North America Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.1.4. North America Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.2.2. Europe Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
8.2.3. Europe Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.2.4. Europe Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.3.2. Asia Pacific Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
8.3.3. Asia-Pacific Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.3.4. Asia Pacific Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.4.2. Latin America Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
8.4.3. Latin America Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.4.4. Latin America Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.5.2. Middle East & Africa Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
8.5.3. Middle East & Africa Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.5.4. Middle East & Africa Smart or AI In-Vitro Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Adaptive Biotechnologies
9.2.2. Aidoc
9.2.3. Anumana
9.2.4. ARUP Laboratories
9.2.5. Atomwise
9.2.6. Bayesian Health
9.2.7. Behold.ai
9.2.8. BGI Genomics Co. Ltd
9.2.9. bioMérieux Diagnostics
9.2.10. Bio-Rad Laboratories, Inc
9.2.11. Cambridge Cognition
9.2.12. Cardiologs (Phillips)
9.2.13. CareDx
9.2.14. Caris Molecular Diagnostics
9.2.15. Cleerly
9.2.16. ClosedLoop AI
9.2.17. CloudMedX Health
9.2.18. Deepcell
9.2.19. Digital Diagnostics
9.2.20. EKF Diagnostics Holdings
9.2.21. Freenome
9.2.22. GE Healthcare
9.2.23. Glooko
9.2.24. Idoven
9.2.25. Illumina
9.2.26. Infohealth
9.2.27. Jade
9.2.28. K Health
9.2.29. Lunit
9.2.30. MaxCyte
9.2.31. Mayo Clinic Laboratories
9.2.32. Medtronic
9.2.33. Merative
9.2.34. Nanox
9.2.35. NIOX Group
9.2.36. Niramai Health Analytix
9.2.37. NVIDIA
9.2.38. Oncohost
9.2.39. OraLiva
9.2.40. Owkin
9.2.41. Oxford Nanopore Technologies
9.2.42. Pacific Biosciences
9.2.43. Paige.AI
9.2.44. PathAI
9.2.45. Perthera
9.2.46. Philips Healthcare
9.2.47. Prognos
9.2.48. Qiagen
9.2.49. Qure.ai
9.2.50. Renalytix
9.2.51. Seegene
9.2.52. Siemens Healthineers
9.2.53. Sophia Genetics
9.2.54. Sysmex
9.2.55. Viz.ai
9.2.56. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們